期刊文献+

Expression of Serum hs-CRP and Lp-PLA2 in Arrhythmia Patients and its Significance 被引量:1

下载PDF
导出
摘要 Objective:The purpose of this study is to examine the expression ofserum high-sensitivity C-reactive protein(hs-CRP)and lipoprotein-associated phospholipase A2(Lp-PLA2)in patients with arrhythmia and its significance.Methods:We selected 136 arrhythmia patients(observation group)who were treated at our hospital from February 2016 to March 2018.Among these patients,50 had premature ventricular contractions,42 had atrial fibrillation,24 had atrial flutter,and 20 had ventricular tachycardia.Simultaneously,we selected 120 healthy volunteers as the control group.We measured serum levels of hs-CRP and Lp-PLA2 in these subjects.Results:The levels of Lp-PLA2 and hs-CRP of the observation group were 210.06±30.46 pg/mL and 13.54±3.16,respectively,which were significantly higher than those of the control group(P<0.05).The serum levels of Lp-PLA2 and hs-CRP of patients with atrial flutter were 260.87±32.24 and 19.84±5.10 pg/mL,respectively,which were significantly higher than those of patients with premature ventricular contractions,atrial fibrillation,and ventricular tachycardia(P<0.05).Serum levels of Lp-PLA2 and hs-CRP were posi-tively correlated(r=0.413,P<0.05).Conclusion:Serum levels of hs-CRP and Lp-PLA2 in arrhythmia patients were significantly elevated and showed some association with the type of arrhythmia.
作者 CONG Xiu-feng
出处 《Chinese Journal of Biomedical Engineering(English Edition)》 2019年第2期66-71,共6页 中国生物医学工程学报(英文版)
  • 相关文献

参考文献8

二级参考文献95

  • 1曹广智,邸文会,张复伟.普罗帕酮与小剂量胺碘酮联合治疗严重快速性心律失常[J].新药与临床,1993,12(1):41-42. 被引量:7
  • 2刘相星,杨春强,王跃明,庄建群,秦毅.室性心律失常患者血浆C反应蛋白水平观察[J].中华心律失常学杂志,2006,10(1):59-60. 被引量:15
  • 3刘甲兴,郑兴.脂蛋白相关磷脂酶A2与动脉粥样硬化[J].中国动脉硬化杂志,2006,14(3):274-276. 被引量:14
  • 4赵元明.冠心病患者血清超敏C反应蛋白变化及其临床意义[J].国际检验医学杂志,2006,27(8):683-685. 被引量:16
  • 5陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社,2010:427.
  • 6Gorczyca-Michta I.Prevalence and predisposing conditions for atrial fibrillation in hospitalized patients with hypertension[J].Kardiol Pol,2013,71(4):352-358.
  • 7Standl E. Statins and beyond: concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes[J]. Diab Vasc Dis Res, 2013, 10(2): 99 - 114.
  • 8Sierra-Johnson J, Fisher RM, Romero-Corral A, et al. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A- I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population[J]. Eur Heart J, 2009, 30(6): 710 - 717.
  • 9Hoogeveen RC, Gaubatz JW, Sun W, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study[J]. Arterioscler Thromb Vasc Biol, 2014, 34(5): 1069 - 1077.
  • 10G6mez M, Vila J, Elosua R, et al. Relationship of lipid oxidation with subclinical atherosclerosis and 10-year coronary events in general population[J]. Atherosclerosis, 2014, 232(1): 134 - 140.

共引文献68

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部